Avanza Fonder’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.9M Buy
211,093
+22,234
+12% +$2.32M 0.4% 41
2026
Q2
$17.1M Sell
188,859
-5,992
-3% -$547K 0.37% 45
2026
Q1
$20M Sell
194,851
-600
-0.3% -$67.7K 0.55% 31
2025
Q4
$24.5M Buy
195,451
+16,161
+9% +$2.06M 0.62% 26
2025
Q3
$24M Buy
179,290
+10,889
+6% +$1.43M 0.62% 21
2025
Q2
$22.9M Buy
168,401
+655
+0.4% +$86.4K 0.68% 18
2025
Q1
$22.1M Sell
167,746
-14,699
-8% -$1.87M 0.73% 19
2024
Q4
$20.6M Buy
+182,445
New +$21.1M 0.61% 24

Other funds holding ABT

Avanza Fonder's ABT Position: Q3 2026 in Review

Avanza Fonder increased its Abbott (ABT) stake by 12% in Q3 2026, buying an estimated $2.32M and bringing the position to 211,093 shares worth $20.9M. The position accounts for 0.4% of the portfolio, ranked #41.

Avanza Fonder first reported a position in ABT in Q4 2024 and has held it in 8 quarters since. The position peaked at $24.5M in Q4 2025. 2,662 funds tracked by Wall St. Rank hold ABT as of Q3 2026.

  • Avanza Fonder held 211,093 shares of Abbott worth $20.9M as of Q3 2026.
  • Avanza Fonder bought 22,234 Abbott shares in Q3 2026, an estimated $2.32M.
  • Abbott made up 0.4% of Avanza Fonder's portfolio in Q3 2026, its #41 holding.
  • Avanza Fonder first reported a position in Abbott in Q4 2024 and has held it in 8 quarters since.
  • Avanza Fonder's Abbott position peaked at $24.5M in Q4 2025.
  • 2,662 funds tracked by Wall St. Rank held Abbott as of Q3 2026.

Based on Avanza Fonder's 13F filing for Q3 2026, filed 13 Oct 2026.